Literature DB >> 26129625

Diversity and plasticity of microglial cells in psychiatric and neurological disorders.

Yutaka Nakagawa1, Kenji Chiba2.   

Abstract

Recent advanced immunological analyses have revealed that the diversity and plasticity of macrophages lead to the identification of functional polarization states (classically activated M1 type and alternatively activated M2 type) which are dependent on the extracellular environment. M1 and M2 polarization states of macrophages play an important role in controlling the balance between pro-inflammatory and anti-inflammatory conditions. Microglial cells are resident mononuclear phagocytes in the central nervous system (CNS), express several macrophage-associated markers, and appear to display functional polarization states similar to macrophages. Like M1 macrophages, M1 polarized microglia can produce pro-inflammatory cytokines and mediators such as interleukin (IL) 1β, IL-6, tumor necrosis factor-α, CC-chemokine ligand 2, nitric oxide, and reactive oxygen species, suggesting that these molecules contribute to dysfunction of neural network in the CNS. On the other hand, M2 polarized microglia can produce anti-inflammatory cytokine, IL-10 and express several receptors that are implicated in inhibiting inflammation and restoring homeostasis. In this review, we summarize the diversity, plasticity, and immunoregulatory functions of M1 and M2 microglia in psychiatric and neurological disorders. Based on these aspects, we propose a contribution of imbalance between M1 and M2 polarization of microglia in bipolar disorder, obesity, amyotrophic lateral sclerosis, and Rett syndrome. Consequently, molecules that normalize the imbalance between M1 and M2 microglial polarization states may provide a beneficial therapeutic target for the treatment of these disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  M1/M2 polarization; Neural network dysfunction; Neuroinflammation; Neurological diseases; Obesity; Psychiatric disorders

Mesh:

Substances:

Year:  2015        PMID: 26129625     DOI: 10.1016/j.pharmthera.2015.06.010

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  53 in total

1.  Galectin-3 in M2 Macrophages Plays a Protective Role in Resolution of Neuropathology in Brain Parasitic Infection by Regulating Neutrophil Turnover.

Authors:  Fredice O Quenum Zangbede; Arun Chauhan; Jyotika Sharma; Bibhuti B Mishra
Journal:  J Neurosci       Date:  2018-06-26       Impact factor: 6.167

2.  The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain.

Authors:  Michelle D Nemetchek; Andrea A Stierle; Donald B Stierle; Diana I Lurie
Journal:  J Ethnopharmacol       Date:  2016-07-26       Impact factor: 4.360

Review 3.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

Review 4.  Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.

Authors:  Li Du; Ying Zhang; Yang Chen; Jie Zhu; Yi Yang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2016-11-09       Impact factor: 5.590

Review 5.  The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in Psychiatric and Neurodegenerative Disorders: Potential Pathogenetic Mechanism and Therapeutic Implications.

Authors:  Yutaka Nakagawa; Shizuo Yamada
Journal:  Cell Mol Neurobiol       Date:  2022-05-30       Impact factor: 5.046

6.  Human umbilical cord mesenchymal stem cells ameliorate depression by regulating Jmjd3 and microglia polarization in myocardial infarction mice.

Authors:  Youyang Zhang; Xinan Wang; Yuhang Li; Ruiping Liu; Jiangqi Pan; Xiane Tang; Shuifen Sun; Jie Liu; Wenlin Ma
Journal:  Psychopharmacology (Berl)       Date:  2021-08-10       Impact factor: 4.530

7.  Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.

Authors:  Allison M Garrison; Jennifer M Parrott; Arnulfo Tuñon; Jennifer Delgado; Laney Redus; Jason C O'Connor
Journal:  Psychoneuroendocrinology       Date:  2018-04-22       Impact factor: 4.905

8.  TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ42 in HMC3 cells.

Authors:  Rumana Akhter; Yvonne Shao; Shane Formica; Maria Khrestian; Lynn M Bekris
Journal:  Mol Immunol       Date:  2021-01-15       Impact factor: 4.407

Review 9.  Immunologic Rejection of Transplanted Retinal Pigmented Epithelium: Mechanisms and Strategies for Prevention.

Authors:  Carson C Petrash; Alan G Palestine; M Valeria Canto-Soler
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 10.  Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders.

Authors:  Silke Miller; Maria-Jesus Blanco
Journal:  RSC Med Chem       Date:  2021-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.